CONGRESS ASSET MANAGEMENT CO /MA - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 369 filers reported holding REPLIGEN CORP in Q2 2020. The put-call ratio across all filers is 1.17 and the average weighting 0.2%.

Quarter-by-quarter ownership
CONGRESS ASSET MANAGEMENT CO /MA ownership history of REPLIGEN CORP
ValueSharesWeighting
Q3 2023$3,805,427
+41.3%
23,932
+25.7%
0.03%
+47.8%
Q2 2023$2,692,267
-6.0%
19,032
+11.9%
0.02%
-14.8%
Q1 2023$2,863,804
+5.6%
17,010
+6.2%
0.03%0.0%
Q4 2022$2,710,992
+8.3%
16,012
+19.7%
0.03%0.0%
Q3 2022$2,503,000
-21.4%
13,378
-31.8%
0.03%
-10.0%
Q2 2022$3,184,000
-94.6%
19,604
-93.7%
0.03%
-94.0%
Q1 2022$58,546,000
-7.5%
311,264
+30.2%
0.50%
+3.3%
Q4 2021$63,317,000
-31.3%
239,076
-25.0%
0.48%
-33.0%
Q3 2021$92,110,000
+3478.5%
318,731
+2372.1%
0.72%
+3168.2%
Q2 2021$2,574,000
-76.7%
12,893
-77.3%
0.02%
-78.0%
Q1 2021$11,044,000
+1.1%
56,809
-0.3%
0.10%
-2.9%
Q4 2020$10,921,000
+16.5%
56,992
-10.3%
0.10%
+1.0%
Q3 2020$9,377,000
+16.2%
63,558
-2.7%
0.10%
+6.2%
Q2 2020$8,072,000
+14.3%
65,304
-10.7%
0.10%
-11.1%
Q1 2020$7,062,000
+0.5%
73,153
-3.7%
0.11%
+25.6%
Q4 2019$7,024,000
+18.8%
75,930
-1.5%
0.09%
+13.2%
Q3 2019$5,910,000
-12.5%
77,058
-1.9%
0.08%
-11.6%
Q2 2019$6,753,000
+44.7%
78,568
-0.5%
0.09%
+41.0%
Q1 2019$4,666,000
+40.0%
78,971
+25.0%
0.06%
+22.0%
Q4 2018$3,333,000
-13.0%
63,192
-8.5%
0.05%0.0%
Q3 2018$3,830,00069,0520.05%
Other shareholders
REPLIGEN CORP shareholders Q2 2020
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders